Your browser doesn't support javascript.
loading
ADGRL3 (LPHN3) variants predict substance use disorder.
Arcos-Burgos, Mauricio; Vélez, Jorge I; Martinez, Ariel F; Ribasés, Marta; Ramos-Quiroga, Josep A; Sánchez-Mora, Cristina; Richarte, Vanesa; Roncero, Carlos; Cormand, Bru; Fernández-Castillo, Noelia; Casas, Miguel; Lopera, Francisco; Pineda, David A; Palacio, Juan D; Acosta-López, Johan E; Cervantes-Henriquez, Martha L; Sánchez-Rojas, Manuel G; Puentes-Rozo, Pedro J; Molina, Brooke S G; Boden, Margaret T; Wallis, Deeann; Lidbury, Brett; Newman, Saul; Easteal, Simon; Swanson, James; Patel, Hardip; Volkow, Nora; Acosta, Maria T; Castellanos, Francisco X; de Leon, Jose; Mastronardi, Claudio A; Muenke, Maximilian.
Afiliação
  • Arcos-Burgos M; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. mauricio.arcos@udea.edu.co.
  • Vélez JI; INPAC Research Group, Fundación Universitaria Sanitas, Bogotá, Colombia. mauricio.arcos@udea.edu.co.
  • Martinez AF; Instituto de Investigaciones Médicas (IIM), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia. mauricio.arcos@udea.edu.co.
  • Ribasés M; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
  • Ramos-Quiroga JA; Universidad del Norte, Barranquilla, Colombia.
  • Sánchez-Mora C; Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
  • Richarte V; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Roncero C; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Cormand B; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Fernández-Castillo N; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Casas M; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Lopera F; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Pineda DA; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Palacio JD; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Acosta-López JE; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Cervantes-Henriquez ML; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Sánchez-Rojas MG; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Puentes-Rozo PJ; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Molina BSG; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Boden MT; Biomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, Spain.
  • Wallis D; Department of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Lidbury B; Addiction and Dual Diagnosis Unit, Departament of Psychiatry, Hospital Universitari Vall d'Hebron-Public Health Agency, Barcelona, Spain.
  • Newman S; Department of Genetics, Microbiology and Statistics, University of Barcelona, Barcelona, CAT, Spain.
  • Easteal S; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Swanson J; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, CAT, Spain.
  • Patel H; Institut de Recerca Sant Joan de Déu (IRSJD), Esplugues, CAT, Spain.
  • Volkow N; Department of Genetics, Microbiology and Statistics, University of Barcelona, Barcelona, CAT, Spain.
  • Acosta MT; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Castellanos FX; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, CAT, Spain.
  • de Leon J; Institut de Recerca Sant Joan de Déu (IRSJD), Esplugues, CAT, Spain.
  • Mastronardi CA; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Muenke M; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Transl Psychiatry ; 9(1): 42, 2019 01 29.
Article em En | MEDLINE | ID: mdl-30696812
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Peptídeos / Transtornos Relacionados ao Uso de Substâncias / Predisposição Genética para Doença / Receptores Acoplados a Proteínas G Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Peptídeos / Transtornos Relacionados ao Uso de Substâncias / Predisposição Genética para Doença / Receptores Acoplados a Proteínas G Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article